Researchers describe how they developed a program for home-based management of indwelling PICC to improve patient self-management.

Researchers sought to assess the impact of Medicaid coverage on diagnosis for pediatric patients and AYAs with lymphoma.

(HealthDay News) — A biomarker consisting primarily of microRNA-based germline biomarkers (mirSNPs), PROSTOX, is valid for predicting radiotherapy (RT)-induced genitourinary (GU) toxicity in patients ...

Current guidelines do not specify the ideal timing between standard TURBT, neoadjuvant chemotherapy, and radical cystectomy in patients with muscle-invasive bladder cancer.

The rising trajectory in the inability to pay for health care is a disturbing trend that is likely to continue and even accelerate,” said Tim Lash.

The Fatigue Scale provides a reliable measure of fatigue in most populations of pediatric patients with cancer.

Pediatric patients with ALL experience, on average, about 15 different symptoms in their chemotherapy journey.